A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer

Hiromitsu Jinno, M. Sakata, T. Hayashida, M. Takahashi, M. Mukai, T. Ikeda, Y. Kitagawa

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences